ICON PLC
ICLR146.180USD
+1.219+0.84%
Horário de mercado （ET）Cotações atrasadas em 15 min
11.81BValor de mercado
14.92P/L TTM
Mais detalhes de ICON PLC Empresa
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Informações da empresa
Código da empresaICLR
Nome da EmpresaICON PLC
Data de listagemMay 15, 1998
Fundado em1989
CEODr. Stephen (Steve) Cutler, Ph.D.
Número de funcionários41900
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 15
EndereçoSouth County Business Park
CidadeDUBLIN
Bolsa de valoresNASDAQ Global Select Consolidated
PaísIreland
Código postal- -
Telefone35312912000
Sitehttps://www.iconplc.com/
Código da empresaICLR
Data de listagemMay 15, 1998
Fundado em1989
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Anne C. Whitaker
Ms. Anne C. Whitaker
Independent Director
Independent Director
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Ronan Murphy
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
2.99B
36.05%
Ireland
2.79B
33.73%
Rest of Europe
1.56B
18.85%
Rest of the World
942.64M
11.38%
Por Empresa
Por Região
Sem dados
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
WCM Investment Management
7.67%
Ninety One UK Limited
3.57%
MFS Investment Management
3.50%
Wellington Management Company, LLP
2.56%
ClearBridge Investments, LLC
2.49%
Other
80.21%
Estatísticas dos acionistas
Acionista
Proporção
WCM Investment Management
7.67%
Ninety One UK Limited
3.57%
MFS Investment Management
3.50%
Wellington Management Company, LLP
2.56%
ClearBridge Investments, LLC
2.49%
Other
80.21%
Tipo
Acionista
Proporção
Investment Advisor/Hedge Fund
40.92%
Investment Advisor
38.63%
Hedge Fund
9.78%
Research Firm
2.93%
Pension Fund
2.80%
Bank and Trust
1.42%
Sovereign Wealth Fund
1.22%
Family Office
1.09%
Family Office
1.09%
Other
0.12%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
1310
81.32M
98.50%
-4.92M
2024Q4
1334
80.88M
97.97%
-5.29M
2024Q3
1290
83.28M
100.86%
-2.02M
2024Q2
1273
83.12M
100.37%
-2.47M
2024Q1
1254
83.08M
100.49%
-3.81M
2023Q4
1237
84.94M
102.98%
-3.00M
2023Q3
1213
86.31M
104.85%
-1.65M
2023Q2
1199
85.95M
104.64%
+2.46M
2023Q1
1190
81.67M
99.73%
-2.49M
2022Q4
1181
81.26M
99.51%
-4.28M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
WCM Investment Management
6.33M
7.67%
-319.37K
-4.80%
Dec 31, 2024
Ninety One UK Limited
2.95M
3.57%
+250.55K
+9.29%
Dec 31, 2024
MFS Investment Management
2.89M
3.5%
-868.59K
-23.12%
Dec 31, 2024
Wellington Management Company, LLP
2.11M
2.56%
-968.73K
-31.43%
Dec 31, 2024
ClearBridge Investments, LLC
2.05M
2.49%
+555.48K
+37.12%
Dec 31, 2024
Templeton Investment Counsel, L.L.C.
1.88M
2.28%
+694.07K
+58.34%
Dec 31, 2024
Lazard Asset Management, L.L.C.
1.83M
2.22%
-525.85K
-22.28%
Dec 31, 2024
AllianceBernstein L.P.
1.82M
2.21%
+502.55K
+38.10%
Dec 31, 2024
T. Rowe Price International Ltd
1.62M
1.96%
+941.77K
+139.75%
Dec 31, 2024
Sustainable Growth Advisers, LP
1.59M
1.93%
+245.80K
+18.24%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
iShares MSCI Ireland ETF
15.67%
Polen Capital International Growth ETF
11.21%
Polen Capital Global Growth ETF
3.5%
VanEck Biotech ETF
3.39%
Motley Fool Global Opportunities ETF
3.07%
Janus Henderson US Sustainable Equity ETF
2.03%
Running Oak Efficient Growth ETF
1.58%
Harbor Health Care ETF
1.4%
Invesco ESG NASDAQ Next Gen 100 ETF
1.25%
Neuberger Berman Small-Mid Cap ETF
1.25%
Ver Mais
iShares MSCI Ireland ETF
Proporção15.67%
Polen Capital International Growth ETF
Proporção11.21%
Polen Capital Global Growth ETF
Proporção3.5%
VanEck Biotech ETF
Proporção3.39%
Motley Fool Global Opportunities ETF
Proporção3.07%
Janus Henderson US Sustainable Equity ETF
Proporção2.03%
Running Oak Efficient Growth ETF
Proporção1.58%
Harbor Health Care ETF
Proporção1.4%
Invesco ESG NASDAQ Next Gen 100 ETF
Proporção1.25%
Neuberger Berman Small-Mid Cap ETF
Proporção1.25%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados